Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
9(30%)
Results Posted
0%(0 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_3
4
13%
Ph not_applicable
17
57%
Ph phase_1
2
7%
Ph phase_2
5
17%

Phase Distribution

2

Early Stage

5

Mid Stage

4

Late Stage

Phase Distribution28 total trials
Phase 1Safety & dosage
2(7.1%)
Phase 2Efficacy & side effects
5(17.9%)
Phase 3Large-scale testing
4(14.3%)
N/ANon-phased studies
17(60.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

55.6%

5 of 9 finished

Non-Completion Rate

44.4%

4 ended early

Currently Active

9

trials recruiting

Total Trials

30

all time

Status Distribution
Active(14)
Completed(5)
Terminated(4)
Other(7)

Detailed Status

Recruiting9
unknown7
Completed5
Not yet recruiting4
Withdrawn3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
30
Active
9
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (7.1%)
Phase 25 (17.9%)
Phase 34 (14.3%)
N/A17 (60.7%)

Trials by Status

terminated13%
not_yet_recruiting413%
withdrawn310%
unknown723%
enrolling_by_invitation13%
completed517%
recruiting930%

Recent Activity

Clinical Trials (30)

Showing 20 of 30 trialsScroll for more
NCT07564440Not Applicable

Hyperthermia Safety Study Uses Temperature Management System to Gently Raise Participant's Body Temperature to a Fever-range Level in a Controlled Setting.

Enrolling By Invitation
NCT07372300Phase 3

Modulated Electro-Hyperthermia in Combination With Multimodal Therapy for Locally Advanced Rectal Cancer

Recruiting
NCT06835049Phase 2

Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)

Recruiting
NCT07118566Phase 2

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

Not Yet Recruiting
NCT07103226Not Applicable

Analysis of Hyperthermia as an Adjunctive Treatment to Evidence-based Clinical Intervention in Subjects With Plantar Fasciitis: a Double-blind Randomized Clinical Trial

Not Yet Recruiting
NCT07099573Not Applicable

Analysis of Hyperthermia as an Adjunctive Treatment to Evidence-based Clinical Intervention in Subjects With Bursitis: a Double-blind Randomized Clinical Trial

Not Yet Recruiting
NCT04398095Not Applicable

Radiotherapy With Hyperthermia in Recurrent and Radiation-Induced Sarcomas

Completed
NCT06942273Not Applicable

Analysis of Hyperthermia as a Complementary Treatment to Evidence-based Clinical Intervention in Subjects With Carpal Tunnel Syndrome:

Not Yet Recruiting
NCT06831981Not Applicable

Hyperthermia With Chemoradiotherapy in Rectal Cancer

Recruiting
NCT05099809

Registry Trial to Evaluate the Safety and Efficacy of Hyperthermia in Locally Advanced Cancers

Recruiting
NCT06431360Not Applicable

Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid

Recruiting
NCT05397262Not Applicable

Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia

Recruiting
NCT06249750Phase 2

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Recruiting
NCT05282784Not Applicable

Hyperthermia With Flexible Electrode-typed 2-MHz Device During Radiotherapy for Solid Tumors

Unknown
NCT02896049

Celsius TCS Hyperthermia System PMCF Trial

Withdrawn
NCT00911079Not Applicable

Pilot Study of a Catheter-based Ultrasound Hyperthermia System

Terminated
NCT03989596Phase 2

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Unknown
NCT03847779Not Applicable

Microcirculatory Vasomotor Changes in Type 2 Diabetes With Peripheral Neuropathy

Completed
NCT03238378Not Applicable

Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours

Recruiting
NCT03238066Not Applicable

Salvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation Therapy

Unknown

Drug Details

Intervention Type
OTHER
Total Trials
30